Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Bethesda North Marriott Hotel and Conference Center

Feb 22, 2027 7:00 AM - Feb 23, 2027 5:00 PM

5701 Marinelli Road, North Bethesda, MD 20852

Advertising and Promotion Regulatory Affairs Conference

Advancing Advertising and Promotion in the Age of Innovation

Early Bird Rates End

DAYS

HOURS

MINUTES

SECONDS

Speakers

Tamei  Elliott, MS

Tamei Elliott, MS

Director, Global Scientific Content, DIA, United States

Tamei Elliott, MS, is the Director of Global Scientific Content at the Drug Information Association (DIA). She leads DIA’s global scientific content strategy, ensuring alignment with regulatory priorities, industry trends, and evolving stakeholder needs across regions. She also established and leads DIA’s Global Science Content Center of Excellence, driving harmonization of content development and strategy across Europe, Asia, North Africa, and the Middle East. With expertise in regulatory science, she brings stakeholders together to address the life sciences industry’s most pressing challenges, driving outcomes that move toward solutions.

Darshan  Kulkarni, JD, PharmD, MS, RPh

Darshan Kulkarni, JD, PharmD, MS, RPh

Principal Attorney, Kulkarni Law Firm, PC, United States

Darshan Kulkarni is a pharmacist-attorney at the Kulkarni Law firm and advises life sciences companies on promotional compliance and medical affairs strategy. He works with pharmaceutical and medical device teams on FDA advertising rules, OPDP risk, influencer and digital promotion, speaker programs, scientific exchange, HCEI communications, and field medical guardrails. Drawing on hands-on experience in compliance, clinical research, and regulatory strategy, he helps companies design review processes, train commercial and medical teams, and navigate enforcement risk while preserving scientific integrity and business objectives.

Twyla  Mosey, PharmD

Twyla Mosey, PharmD

Acting Office Director, OPDP, CDER , FDA, United States

Twyla Mosey, PharmD, RPh is the Acting Director of the Office of Prescription Drug Promotion (OPDP) at the Food and Drug Administration. She ensures that OPDP fulfills its mission of protecting the public health by overseeing office operations including compliance activities, advisory and labeling recommendations, and external outreach activities. Over the past 18 years, Twyla has held various leadership roles within the Agency and pharmaceutical industry. She received her Doctor of Pharmacy degree from Florida Agricultural and Mechanical University and completed several fellowships including a Post-Doctoral Pharmaceutical Industry Fellowship.

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.